Back to Authors

Funovics, Philipp T.

https://orcid.org/0000-0001-9662-5942

Mayo Clinic

University of Vienna

Citations 2

Controversies in orthopaedic oncology
Thorkildsen, Joachim , Kurisunkal, Vineet , Puri, Ajay , Houdek, Matthew T. , Boyle, Richard A. , Ebeid, Walid , Botello, Eduardo , Laitinen, Minna , Funovics, Philipp T. , Jeys, Lee M , Thorkildsen, Joachim , Kurisunkal, Vineet , Puri, Ajay , Ruggieri, Pietro , Houdek, Matthew T , Ebeid, Walid , Botello, Eduardo , Morris, Guy V , Laitinen, Minna K , Jeys, Lee , Ruggieri, Pietro

The Bone & Joint Journal | May 1, 2024 | Volume: 106-B | Issue: 5 | Pages: 425-429

10.1302/0301-620x.106b5.bjj-2023-1381 Get It

Chondrosarcoma is the second most common surgically treated primary bone sarcoma. Despite a large number of scientific papers in the literature, there is still significant controversy about diagnostics, treatment of the primary tumour, subtypes, and complications. Therefore, consensus on its day-to-day treatment decisions is needed. In January 2024, the Birmingham Orthopaedic Oncology Meeting (BOOM) attempted to gain global consensus from 300 delegates from over 50 countries. The meeting focused on these critical areas and aimed to generate consensus statements based on evidence amalgamation and expert opinion from diverse geographical regions. In parallel, periprosthetic joint infection (PJI) in oncological reconstructions poses unique challenges due to factors such as adjuvant treatments, large exposures, and the complexity of surgery. The meeting debated two-stage revisions, antibiotic prophylaxis, managing acute PJI in patients undergoing chemotherapy, and defining the best strategies for wound management and allograft reconstruction. The objectives of the meeting extended beyond resolving immediate controversies. It sought to foster global collaboration among specialists attending the meeting, and to encourage future research projects to address unsolved dilemmas. By highlighting areas of disagreement and promoting collaborative research endeavours, this initiative aims to enhance treatment standards and potentially improve outcomes for patients globally. This paper sets out some of the controversies and questions that were debated in the meeting.Cite this article: Bone Joint J 2024;106-B(5):425–429.
Classification of failure of limb salvage after reconstructive surgery for bone tumours
Ruggieri, Pietro , Windhager, Reinhard , Funovics, Philipp T. , Gibbons, C. L. M. H. , Hornicek, Francis J. , Temple, H. Thomas , Letson, G. Douglas , Henderson, Eric R. , O’Connor, Mary I. , Guo, Wei , Ruggieri, Pietro

The Bone & Joint Journal | November 4, 2014 | Volume: 96-B | Issue: 11 | Pages: 1436-1440

10.1302/0301-620x.96b11.34747 Get It

Previous classification systems of failure of limb salvage focused primarily on endoprosthetic failures and lacked sufficient depth for the effective study of the causes of failure. In order to address these inadequacies, the International Society of Limb Salvage (ISOLS) formed a committee to recommend revisions of the previous systems. The purpose of this study was to report on their recommendations. The modifications were prepared using an earlier, evidence-based model with subclassification based on the existing medical literature. Subclassification for all five primary types of failure of limb salvage following endoprosthetic reconstruction were formulated and a complementary system was derived for the failure of biological reconstruction. An additional classification of failure in paediatric patients was also described. Limb salvage surgery presents a complex array of potential mechanisms of failure, and a complete and precise classification of types of failure is required. Earlier classification systems lacked specificity, and the evidence-based system outlined here is designed to correct these weaknesses and to provide a means of reporting failures of limb salvage in order to allow the interpretation of outcome following reconstructive surgery. Cite this article: Bone Joint J 2014;96-B:1436–40.